[
  {
    "ts": "2026-02-18T02:21:20+00:00",
    "headline": "This State Has More Millionaires Per Capita Than Any Other",
    "summary": "There are many ways to describe America. Some might call it a veritable patchwork of diverse cultures and social strata. That’s a fancy way of saying that prosperity is concentrated in some U.S. states more than in others. As a result, a handful of America’s 50 states have more millionaires than others. By the process ... This State Has More Millionaires Per Capita Than Any Other",
    "url": "https://247wallst.com/investing/2026/02/17/this-state-has-more-millionaires-per-capita-than-any-other/",
    "source": "24/7 Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "c78046f0-1ca5-32dc-85cf-6f8c38a5db54",
      "content": {
        "id": "c78046f0-1ca5-32dc-85cf-6f8c38a5db54",
        "contentType": "STORY",
        "title": "This State Has More Millionaires Per Capita Than Any Other",
        "description": "",
        "summary": "There are many ways to describe America. Some might call it a veritable patchwork of diverse cultures and social strata. That’s a fancy way of saying that prosperity is concentrated in some U.S. states more than in others. As a result, a handful of America’s 50 states have more millionaires than others. By the process ... This State Has More Millionaires Per Capita Than Any Other",
        "pubDate": "2026-02-18T02:21:20Z",
        "displayTime": "2026-02-18T02:21:20Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/24_7_wall_st__718/f7109cc114790579cb27b509e454b2fa",
          "originalWidth": 2560,
          "originalHeight": 1707,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BsdaEb1kKl4fYOmiuFHAbQ--~B/aD0xNzA3O3c9MjU2MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/24_7_wall_st__718/f7109cc114790579cb27b509e454b2fa.cf.webp",
              "width": 2560,
              "height": 1707,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.yBu0G0aPHwBbKcaFQSnrA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/24_7_wall_st__718/f7109cc114790579cb27b509e454b2fa.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "24/7 Wall St.",
          "url": "https://247wallst.com/"
        },
        "canonicalUrl": {
          "url": "https://247wallst.com/investing/2026/02/17/this-state-has-more-millionaires-per-capita-than-any-other/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/state-more-millionaires-per-capita-022120447.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-18T08:06:29+00:00",
    "headline": "The Patent Cliff Is a Hill: Why Merck's Diversification Engine Makes MRK a Buy",
    "summary": "Diversification Beyond the Keytruda Cliff",
    "url": "https://finance.yahoo.com/news/patent-cliff-hill-why-mercks-080629498.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "35ef5253-eb9f-332e-ac8c-83adc750f78c",
      "content": {
        "id": "35ef5253-eb9f-332e-ac8c-83adc750f78c",
        "contentType": "STORY",
        "title": "The Patent Cliff Is a Hill: Why Merck's Diversification Engine Makes MRK a Buy",
        "description": "",
        "summary": "Diversification Beyond the Keytruda Cliff",
        "pubDate": "2026-02-18T08:06:29Z",
        "displayTime": "2026-02-18T08:06:29Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/patent-cliff-hill-why-mercks-080629498.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/patent-cliff-hill-why-mercks-080629498.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-18T10:16:00+00:00",
    "headline": "$198.39 Bn Active Pharmaceutical Ingredients (API) Markets, 2030 by Synthesis (synthetic, Biotech), Potency (HPAPI), Product (mAbs, Hormones), Drug (OTC, Rx), Application (Diabetes, Oncology)",
    "summary": "The global active pharmaceutical ingredients (API) market is poised to reach USD 198.39 billion by 2030, witnessing a CAGR of 6.6% from USD 144.20 billion in 2025. The API market's growth is significantly driven by expanding oncology, rare disease, and diabetes pipelines, bolstered by peptide-based drugs like Semaglutide. In 2024, the pharmaceutical and biotechnology segment captured the largest market share, reinforced by in-house manufacturing of high-value drugs and increasing outsourcing for",
    "url": "https://finance.yahoo.com/news/198-39-bn-active-pharmaceutical-101600490.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "667d5d85-1890-3c02-8e2b-8151284ca38a",
      "content": {
        "id": "667d5d85-1890-3c02-8e2b-8151284ca38a",
        "contentType": "STORY",
        "title": "$198.39 Bn Active Pharmaceutical Ingredients (API) Markets, 2030 by Synthesis (synthetic, Biotech), Potency (HPAPI), Product (mAbs, Hormones), Drug (OTC, Rx), Application (Diabetes, Oncology)",
        "description": "",
        "summary": "The global active pharmaceutical ingredients (API) market is poised to reach USD 198.39 billion by 2030, witnessing a CAGR of 6.6% from USD 144.20 billion in 2025. The API market's growth is significantly driven by expanding oncology, rare disease, and diabetes pipelines, bolstered by peptide-based drugs like Semaglutide. In 2024, the pharmaceutical and biotechnology segment captured the largest market share, reinforced by in-house manufacturing of high-value drugs and increasing outsourcing for",
        "pubDate": "2026-02-18T10:16:00Z",
        "displayTime": "2026-02-18T10:16:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/f17019bd7ddea4815dee288c80d9b7fe",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "Active Pharmaceutical Ingredients (API) Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/82uh4eZvFTWMRxmA7hFB.Q--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/f17019bd7ddea4815dee288c80d9b7fe.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/weD1LQLKgiMB6mDCx2zL8A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/f17019bd7ddea4815dee288c80d9b7fe.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/198-39-bn-active-pharmaceutical-101600490.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/198-39-bn-active-pharmaceutical-101600490.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "TEVA"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-18T11:45:00+00:00",
    "headline": "Merck and Mayo Clinic Announce New Research and Development Collaboration to Support AI-Enabled Drug Discovery and Precision Medicine",
    "summary": "RAHWAY, N.J., & ROCHESTER, Minn., February 18, 2026--Merck and Mayo Clinic today announced a R&D agreement to apply artificial intelligence (AI), advanced analytics and data to support drug discovery.",
    "url": "https://finance.yahoo.com/news/merck-mayo-clinic-announce-research-114500310.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "7e09b530-9654-390a-883f-36a81af578a8",
      "content": {
        "id": "7e09b530-9654-390a-883f-36a81af578a8",
        "contentType": "STORY",
        "title": "Merck and Mayo Clinic Announce New Research and Development Collaboration to Support AI-Enabled Drug Discovery and Precision Medicine",
        "description": "",
        "summary": "RAHWAY, N.J., & ROCHESTER, Minn., February 18, 2026--Merck and Mayo Clinic today announced a R&D agreement to apply artificial intelligence (AI), advanced analytics and data to support drug discovery.",
        "pubDate": "2026-02-18T11:45:00Z",
        "displayTime": "2026-02-18T11:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/716a3574f3252f3adb867c7074c30b14",
          "originalWidth": 480,
          "originalHeight": 217,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IzXLL73YPVEVavNKEpSaCw--~B/aD0yMTc7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/716a3574f3252f3adb867c7074c30b14.cf.webp",
              "width": 480,
              "height": 217,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7dN6iDWbc13FegoA1rkXBQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/716a3574f3252f3adb867c7074c30b14.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/merck-mayo-clinic-announce-research-114500310.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-mayo-clinic-announce-research-114500310.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-18T15:17:10+00:00",
    "headline": "Merck & Co. (MRK) Advances on Robust Keytruda Sales and Positive Clinical Trial Results",
    "summary": "Impax Asset Management‘s “Impax US Sustainable Economy Fund” released its Q4 2025 investor letter. A copy of the letter can be downloaded here. The fund reported that equity markets remained volatile during the quarter amid concerns over elevated valuations and financing for large-scale data center investments, although the portfolio modestly outperformed the Russell 1000 benchmark […]",
    "url": "https://finance.yahoo.com/news/merck-co-mrk-advances-robust-151710546.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "7cd8ee98-f92a-32e1-ab3b-fa5b7f286874",
      "content": {
        "id": "7cd8ee98-f92a-32e1-ab3b-fa5b7f286874",
        "contentType": "STORY",
        "title": "Merck & Co. (MRK) Advances on Robust Keytruda Sales and Positive Clinical Trial Results",
        "description": "",
        "summary": "Impax Asset Management‘s “Impax US Sustainable Economy Fund” released its Q4 2025 investor letter. A copy of the letter can be downloaded here. The fund reported that equity markets remained volatile during the quarter amid concerns over elevated valuations and financing for large-scale data center investments, although the portfolio modestly outperformed the Russell 1000 benchmark […]",
        "pubDate": "2026-02-18T15:17:10Z",
        "displayTime": "2026-02-18T15:17:10Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/f4f6ab0951c1038aa2303274fb6c0b9d",
          "originalWidth": 1280,
          "originalHeight": 853,
          "caption": "Merck & Co., Inc. (MRK) Advances on Robust Keytruda Sales and Positive Clinical Trial Results",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OdUZhzJneaC3psvAqDZt0Q--~B/aD04NTM7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/f4f6ab0951c1038aa2303274fb6c0b9d.cf.webp",
              "width": 1280,
              "height": 853,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/igPuOk294DrUoWTvXb9e3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/f4f6ab0951c1038aa2303274fb6c0b9d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/merck-co-mrk-advances-robust-151710546.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-co-mrk-advances-robust-151710546.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]